TransCode Therapeutics Inc.

RNAZ | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.76

+$0.11 (+6.67%)

At close: Sep 21, 2026, 4:00 PM ET

$1.84

+$0.08 (+4.55%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	17.81M	5.81M	2.77M	4.97M	20.83M	828.02K
Short-Term Investments	n/a	n/a	n/a	9.41K	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	-1	111.86K	111.86K	0	0	224.15K
Receivables	3.25M	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	529.04K	517.48K	1.14M	1.02M	1.84M	n/a
Total Current Assets	21.98M	7.09M	4.46M	7.38M	22.73M	831.22K
Property-Plant & Equipment	370.68K	89.31K	602.4K	208.58K	206.27K	n/a
Goodwill & Intangibles	140.04M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	140.41M	201.16K	714.26K	208.58K	206.27K	224.15K
Total Assets	162.4M	7.29M	5.17M	7.59M	22.94M	1.06M
Account Payables	3.12M	2.58M	n/a	n/a	2.02M	n/a
Deferred Revenue	n/a	n/a	27.06K	n/a	30.53K	n/a
Short-Term Debt	n/a	38.29K	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	26.11K	157.04K	57.82K	-2.02M	-1
Total Current Liabilities	3.49M	2.77M	3.49M	4.35M	2.53M	404.86K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	2.09M
Other Long-Term Liabilities	148.34M	6.54M	n/a	n/a	n/a	1.97M
Total Long-Term Liabilities	148.57M	6.54M	38.29K	n/a	n/a	4.06M
Total Liabilities	152.06M	9.31M	3.53M	4.35M	2.53M	4.46M
Total Debt	n/a	38.29K	450.57K	n/a	n/a	2.09M
Book Value	10.34M	-2.02M	1.64M	3.24M	20.4M	-3.41M
Book Value Per Share	14.99	-5.67	302.49	199.78	1.94K	-427.15
Common Stock	92	103	63	2	1.29K	464
Retained Earnings	-97.86M	-63.2M	-46.42M	-27.87M	-10.31M	-3.46M
Comprehensive Income	n/a	n/a	0	0	0	n/a
Shareholders Equity	10.34M	-2.02M	1.64M	3.24M	20.4M	-3.41M
Total Investments	n/a	n/a	n/a	9.41K	n/a	n/a